Fig. 2
From: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
Low expression of kallistatin predicted poor prognosis of HGSOC. (a) Overall survival rates of HGSOC patients in the low versus high kallistatin expression group. (b) Progression free survival rates of HGSOC patients in the low versus high kallistatin expression group. (c) Overall survival analysis of serous ovarian cancer patients in data from the KM plotter database. (d, e) Forest plots depicting the results of the multivariate analysis of OS and PFS assessed by the Cox proportional hazard regression model. *p < 0.05, **p < 0.01, ***p < 0.001